Oxford Immunotec to Participate in Two Upcoming Investor Conferences
August 21 2019 - 9:15AM
Oxford Immunotec Global PLC (Nasdaq:OXFD), or the Company, a
global, high-growth diagnostics company, today announced that Dr.
Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin,
Chief Financial Officer, will be participating in two upcoming
investor conferences.
- The 2019 Wells Fargo Healthcare Conference on Wednesday,
September 4, 2019 at the Westin Copley Place Hotel in Boston,
MA.
- Baird 2019 Global Healthcare Conference on Thursday, September
5, 2019, at 10:15 a.m. ET at the InterContinental New York Barclay
Hotel in New York, NY.
About Oxford Immunotec
Oxford Immunotec Global PLC is a global, high-growth diagnostics
company focused on developing and commercializing proprietary
assays for immunology and infectious disease. The Company's
T-SPOT®.TB test has been approved for sale in over 50 countries,
including the United States, where it has received pre-market
approval from the Food and Drug Administration, Europe, where it
has obtained a CE mark, as well as Japan and China. The
Company is headquartered near Oxford, U.K. and in Marlborough,
MA. Additional information can be found at
www.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford
Immunotec Ltd.
CONTACTS:
For Media and Investor Inquiries: Matt
McLaughlinChief Financial OfficerOxford ImmunotecTel: +1 (508)
573-9953mtmclaughlin@oxfordimmunotec.com
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Immunotec Global (NASDAQ:OXFD)
Historical Stock Chart
From Apr 2023 to Apr 2024